AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 142 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $133,635 | -31.2% | 20,946 | +19.7% | 0.00% | – |
Q2 2023 | $194,108 | -18.4% | 17,503 | +13.0% | 0.00% | – |
Q1 2023 | $237,772 | -10.9% | 15,490 | +28.8% | 0.00% | – |
Q4 2022 | $266,946 | +52.5% | 12,030 | +12.5% | 0.00% | – |
Q3 2022 | $175,000 | -84.8% | 10,697 | -77.1% | 0.00% | -100.0% |
Q3 2021 | $1,151,000 | -3.4% | 46,734 | -3.1% | 0.00% | 0.0% |
Q2 2021 | $1,192,000 | +132.4% | 48,232 | +105.0% | 0.00% | – |
Q1 2021 | $513,000 | -7.7% | 23,526 | +8.1% | 0.00% | – |
Q4 2020 | $556,000 | – | 21,768 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
AtonRa Partners | 18,970 | $121,029 | 0.25% |
Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |